FCAAIA Notes: I do not want to see my patients with food allergy crippled by their dietary limitations. They and their families should live entirely normal lives with exception of avoiding the offending food(s).
I know accidents happen, so like the Boy Scouts, it is important to “Be Prepared”. Continue reading “KIDS WITH FOOD ALLERGIES OFTEN PUT AT RISK BY THEIR PARENTS”
FCAAIA Notes: In pediatrics, most medications re dosed by weight. Now, there is an auto-injectable epinephrine dosed for infants and toddlers. However, if you have a baby and have a 0.15 mg auto-injector, I would not discard it. First of all, Continue reading “FDA OKS EPINEPHRINE AUTO-INJECTOR FOR SMALL CHILDREN”
FCAAIA Notes: Until now, I have only posted articles about a specific brand of a medication if it is the only one available in its class. However, the absence of Auvi-Q has been a real problem from many patients, especially because the manufacturers of its competitor (EpiPen by Mylan) raised its price prohibitively high. Continue reading “AUVI-Q RETURNING TO MARKET IN 2017”
FCAAIA Notes: Epinephrine (adrenalin) is the treatment of choice for anaphylaxis. Delay in administration of epinephrine is the major risk factor for poor outcomes in anaphylaxis, including anaphylactic death.
Patients at risk for anaphylaxis should own an epinephrine auto-injector (e.g., EpiPen) and know how to use it. Continue reading “ANAPHYLAXIS: EARLY EPINEPHRINE TIED TO FEWER OVERALL DOSES”